ホーム

1,10-Phenanthroline

1,10-Phenanthroline

規格

66-71-7CAS番号
200-629-2EC番号
1,10-phenanthrolineIUPAC名
C12H8N2化学式
180.2 g/mol分子量
1,10-phenanthroline; 66-71-7; o-phenanthroline; 4,5-diazaphenanthrene; orthophenanthroline; 1,10-o-phenanthroline; beta-phenanthroline; 2-phenanthroline; DTXSID1025857; O-PHE; W4X6ZO7939; NSC-4265; NSC-203545; DTXCID405857; CHEBI:44975; (OP)2Cu(I); RefChem:410355; 200-629-2; Phenanthroline; MFCD00011678; 1,10-Phenanthroline anhydrous; 1,10-Fenanthrolin; .beta.-Phenanthroline; [1,10]phenanthroline; MLS000069797; CHEMBL415879; NSC203545; phen; NSC4265; SMR000058190; pyridino[3,2-h]quinoline; MLS002701886; CAS-66-71-7; PHN; 1,10-Fenanthrolin [Czech]; Activ-8; CCRIS 4855; 1,10-Phenanthroline, Anhydrous; EINECS 200-629-2; Phenanthroline, 1,10-; NSC 203545; phenantroline; UNII-W4X6ZO7939; ?-Phenanthroline; Cyto5A5; 1,10-phenanthrolin; 1,10-phenantroline; 1,10-phenathroline; 1,10 phenanthroline; 1,10-Fenanthroline; 1.10-phenanthroline; 1,1 0-phenanthroline; Opera_ID_711; [1,10]-Phenanthroline; Lopac-P-9375; PHENANTHROLINE, O-; o-Phenanthroline, anhydrous; Activ-8 in hexylene glycol; cid_1318; SCHEMBL8312; NCIStruc1_000192; NCIStruc2_000199; Lopac0_000985; SCHEMBL25101; SCHEMBL25121; SCHEMBL67041; SCHEMBL67915; SCHEMBL68795; O-PHENANTHROLINE [MI]; orb1224293; orb1301370; SCHEMBL2406866; SCHEMBL2407179; SCHEMBL2407335; SCHEMBL2407347; SCHEMBL2407438; SCHEMBL2407975; SCHEMBL2408042; SCHEMBL2409386; SCHEMBL2409550; SCHEMBL2409957; SCHEMBL2410620; SCHEMBL2413550; SCHEMBL28366418; SCHEMBL29354015; SCHEMBL29367277; GTPL12425; WLN: T B666 CN NNJ; NCI4265; 1,10-Phenanthroline, >=99%; HMS2234D03; HMS3263E11; HMS3371F11; HMS5086M04; Tox21_201998; Tox21_303111; Tox21_500985; BDBM50092158; CCG-38059; EBC-44315; NCGC00013043; s6830; SBB089685; STL069281; AKOS000281773; AC-3314; CS-W004544; DB02365; FP26867; HY-W004544; LP00985; SDCCGSBI-0050958.P003; NCGC00013043-02; NCGC00013043-03; NCGC00013043-04; NCGC00013043-05; NCGC00013043-06; NCGC00013043-07; NCGC00013043-08; NCGC00013043-09; NCGC00013043-10; NCGC00013043-13; NCGC00091201-01; NCGC00091201-02; NCGC00091201-03; NCGC00091201-04; NCGC00257123-01; NCGC00259547-01; NCGC00261670-01; AC-18353; AS-14043; NCI60_003976; SY004548; DB-013750; EU-0100985; NS00010855; P0221; P0879; P1826; P2099; ST45051101; T5983; EN300-35040; C00604; O10332; P 9375; AA-860/25004133; F076839; Q416005; SR-01000076093; CU-00000000156-1; doi:10.14272/DGEZNRSVGBDHLK-UHFFFAOYSA-N.1; SR-01000076093-1; F3377-1129; 1,10-Phenanthroline in combination with isoniazid and rifampicin; InChI=1/C12H8N2/c1-3-9-5-6-10-4-2-8-14-12(10)11(9)13-7-1/h1-8別名

1,10-Phenanthrolineを販売する企業